Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By boosting these https://esmeecjyu235185.targetblogs.com/36701744/retatrutide-a-promising-new-treatment-for-obesity